S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CNTX Context Therapeutics Inc

1.14

-0.01 (-0.87%)

After Hours

Last Updated: 09:06:44

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics Inc News

Form 8-K - Current report
Tuesday 24 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics to Participate in Upcoming Investor Conferences in November
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Wednesday 16 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 23 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 September 2024 (3 months ago) • Edgar (US Regulatory)

More Context Therapeutics Inc News Articles

PIMCO Low Duration Euro ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions